Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?

Minimization of immunosuppression and administration of antiretrovirals have been recommended for kidney transplant recipients (KTRs) with coronavirus disease 2019 (COVID-19). However, outcomes remain poor. Given the likely benefit of cyclosporine because of its antiviral and immunomodulatory effect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Transplant
Autors principals: Rodriguez-Cubillo, Beatriz, de la Higuera, Maria Angeles Moreno, Lucena, Rafael, Franci, Elena V., Hurtado, Maria, Romero, Natividad C., Moreno, Antolina R., Valencia, Daniela, Velo, Mercedes, Fornie, Iñigo S., Sanchez-Fructuoso, Ana I.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2020
Matèries:
Brief Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7307110/
https://ncbi.nlm.nih.gov/pubmed/32529737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.16141
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars